Below are the earnings highlights for Neurocrine Biosciences Inc (NBIX):
Earnings: $43.4 million in Q1 vs. -$76.6 million in the same period last year. EPS: $0.42 in Q1 vs. -$0.79 in the same period last year. Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $124.8 million or $1.20 per share for the period.
Analysts projected $1.01 per share Revenue: $515.3 million in Q1 vs. $420.4 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.